Clinical Trial Update: Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (NEST-3) evaluating the efficacy and safety of transcranial laser therapy administered within 24 hours of onset for acute ischemic stro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Transcranial Laser Therapy

Snippet

Sponsor: PhotoThera, Inc | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED